MD Anderson Symptom Inventory - Chronic Myeloid Leukemia Module (MDASI-CML)

Williams LA; Garcia-Gonzalez A; Williams JL; Ault PS; Mendoza TR; Cleeland CS; Mobley GM; Cortes JE


Basic description

  • Published in 2010
  • The MDASI-CML is composed of the previously published general questionnaire MDASI (Cleeland et al, 2000) and a Chronic Myeloid Leukemia (CML)-specific module

Williams LA; Garcia-Gonzalez A; Williams JL; Ault PS; Mendoza TR; Cleeland CS; Mobley GM; Cortes JE

Copyright 2000 The University of Texas M. D. Anderson Cancer Center. All rights reserved

The M. D. Anderson Symptom Inventory copyright is held by The University of Texas MD Anderson Cancer Center and administered by the MDASI’s developer, Charles S. Cleeland, PhD. The copyright applies to the MDASI and all its derivatives in any language.
To assess the severity of multiple chronic myeloid leukemia-related symptoms and the impact of these symptoms on daily functioning
Therapeutic area
  • Neoplasms
Therapeutic indication

Leukemia, Myeloid

Philadelphia-chromosome-positive chronic myeloid leukemia (CML)
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English
18 translation(s)
Bibliographic reference(s) of the original questionnaire

Williams LA, Garcia-Gonzalez A, Ault P, et al. A new symptom measure in chronic myeloid leukemia. American Society of Clinical Oncology 47th Annual Meeting, Chicago IL, Jun 3-7, 2011. J Clin Oncol 29(15 Suppl), 2011; e19545 (Abstract)

Williams LA, Cortes JE, Ault P, Garcia-Gonzalez A, Williams JL, Cleeland CS. Including patient input in patient-reported outcome instrument development: examples from the MDASI-CML. American Society of Hematology 2010 Annual Meeting, Orlando FL, Dec 4-7, 2010. Blood116(21): 1065, 2010; 2573 (Abstract)

Williams LA, Garcia Gonzalez AG, Ault P, Mendoza TR, Sailors ML, Williams JL, Huang F, Nazha A, Kantarjian HM, Cleeland CS, Cortes JE. Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood. 2013 Aug 1;122(5):641-7 (Full-text article)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us